Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

SKB reports 5-HT2B/2C antagonists for CNS indications

April 26, 1996

Adolor aims to advance ADL-2-1294 into clinical trials

April 26, 1996

BMS antimigraine agent poised to enter clinical trials

April 26, 1996

NPC-18688 displays long-lasting antihyperalgesic effects in rodents

April 26, 1996

SKB claims morphinoid derivatives

April 26, 1996

OT-7100, Otsuka's new analgesic for peripheral pain

April 26, 1996

Combined thrombolytic/neuroprotective agents more effective in treating stroke

April 19, 1996

Nerve growth synthesis inducers produce neuroprotective effects

April 19, 1996

SKB reports calcium antagonists for stroke

April 19, 1996

New Takeda compounds suppress increased vascular permeability

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
SERCA inhibitor shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers...